Menu

The Oncology Institute, Inc. STLN

Full chart Compare
Set alert

Price alert · STLN

All alert types
3.62 USD -3.08 (-45.97%)

At closeNov 6, 2026, 7:18 PM EST

3.63 +0.01 +0.28%

After hours · Nov 6, 7:18 PM ET

3.35 Day range 6.43
2.38 52-week range 7.05
YTD
+1.69%
1 year
-4.99%

Revenue & Expenses

Income Tax Benefit → Expenses: $131.00KExpenses → Selling, General & Admin: $105.57MExpenses → Other Operating Expenses: $6.94MExpenses → Interest Expense: $11.28MExpenses → Other Expenses: $13.38MGross Profit → Expenses: $76.44MRevenue → Gross Profit: $76.44MRevenue → Cost of Revenue: $426.29MNet Loss → Expenses: $60.61MIncome Tax Benefit$131.00KGross Profit$76.44MNet Loss$60.61MCost of Revenue$426.29MExpenses$137.17MSelling, General & Admin$105.57MOther Operating Expenses$6.94MInterest Expense$11.28MOther Expenses$13.38MRevenue$502.73M

Latest period ending Dec 31, 2025 · select a line to chart its full history

STLN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
502.73M393.41M324.24M252.48M203.00M
76.44M54.00M59.57M52.09M40.85M
-36.08M-60.12M-77.02M-81.95M-45.86M
-60.61M-64.66M-83.07M68.00K-10.63M
-50,305.00-53,005.00-67,877.00-0.21-0.16
STLN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
33.56M49.67M33.49M14.01M115.17M
164.66M172.72M209.24M261.67M203.44M
180.38M169.13M152.22M138.49M99.28M
103.69M123.15M119.67M108.18M183.00K
-15.72M3.59M57.02M123.17M104.16M
STLN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-24.59M-26.54M-36.31M-61.76M-32.68M
-3.07M46.21M62.64M-131.61M-12.15M
11.56M-3.49M-6.85M92.21M154.01M
-3.20M-3.79M-4.57M-5.53M-2.85M
-16.10M16.18M19.48M-101.16M109.18M